Compare TR & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TR | PBH |
|---|---|---|
| Founded | 1896 | 1996 |
| Country | United States | United States |
| Employees | 2100 | 600 |
| Industry | Specialty Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.5B |
| IPO Year | N/A | 2004 |
| Metric | TR | PBH |
|---|---|---|
| Price | $43.70 | $51.91 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $75.33 |
| AVG Volume (30 Days) | 109.4K | ★ 424.6K |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.82% | N/A |
| EPS Growth | N/A | ★ 2.88 |
| EPS | N/A | ★ 2.78 |
| Revenue | N/A | ★ $975,777,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.07 |
| P/E Ratio | $32.36 | ★ $18.87 |
| Revenue Growth | N/A | ★ 36.77 |
| 52 Week Low | $29.13 | $51.28 |
| 52 Week High | $44.27 | $88.00 |
| Indicator | TR | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 65.46 | 22.11 |
| Support Level | $40.07 | N/A |
| Resistance Level | N/A | $63.56 |
| Average True Range (ATR) | 1.26 | 2.28 |
| MACD | 0.12 | -0.69 |
| Stochastic Oscillator | 93.73 | 9.09 |
Tootsie Roll Industries Inc manufactures and sells confectionery products. Notable varieties include Tootsie Roll and Tootsie Pops, Charms, Blow-Pops, Dots, Junior Mints, Sugar Daddy and Sugar Babies, Andes, Dubble Bubble, Razzles among others. The company sells its products to wholesale distributors and directly to retail stores. Geographically, it generates a majority of its revenue from the United States and rest from Canada, Mexico and other regions.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.